Sumatriptan (Imitrex)
As the first highly effective and well-tolerated drug for the acute treatment of migraine, it was hailed as a medical breakthrough - Patrick P.A. Humphrey PhD

image by: HWN
HWN Suggests
Migraine Killer
The history of Imitrex goes all the way back to 1972, when Glaxo launched a research program to develop a new migraine drug. The company’s goal was to find a chemical that could narrow swollen blood vessels in the head, thereby stopping the pain of migraine headaches. But it was also important that the drug not narrow or squeeze blood vessels in the heart, because this could cause spasm in those vessels and trigger a heart attack. More than a decade passed before Glaxo scientists came up with Imitrex. The drug mimicked serotonin, a chemical produced naturally in the body. Serotonin contracts blood vessels by acting on their cells via the gateways or “receptors” known as 5HT. Glaxo researchers…Featured
Why Sumatriptan (Imitrex) for Migraine Relief May Be Worth Revisiting
Sumatriptan is usually the first acute treatment healthcare providers prescribe for someone with a new migraine diagnosis. If you’re a longtime migraine warrior, you’ve probably tried sumatriptan in at least one form. If you didn’t get the best results from sumatriptan the first time around, there are good reasons it may be worth revisiting...
Articles of Interest
Sumatriptan poisoning and its clinical presentation in humans: A case report
This potent drug acts on 5‐HT1 receptors, leading to vasoconstriction. Like other medications, it has side effects like tachycardia, transient hypertension, behavioral instability, facial edema, angle‐closure glaucoma, cardiac arrhythmias, abdominal pain, bloody diarrhea because of vascular ischemia, splenic infarction, hepatotoxicity, and Raynaud's syndrome.
Sumatriptan side effects and how to avoid them
Many people achieve significant relief from migraine symptoms using sumatriptan in its various formats, but this medication is not right for everyone. Side effects can sometimes be serious, and sumatriptan can worsen underlying medical conditions or interact with other medications being taken.
Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine
Even though sumatriptan has been a major step forward in providing a new specific therapy for the treatment of migraines, there are still are limitations in its use. There is still an unmet need to develop new non-triptan, anti-migraine drugs which act as effective treatment for those who suffer with migraines.
The Discovery and Development of the Triptans, a Major Therapeutic Breakthrough
The prototypical triptan, sumatriptan, first became available in Europe in 1991 and revolutionized the treatment of this debilitating condition that affects millions of people throughout the world. As the first highly effective and well-tolerated drug for the acute treatment of migraine, it was hailed as a medical breakthrough. Many clinicians still describe, in both private and public forums, their first experience of witnessing at first hand the “miraculous” and rapid disappearance of their patient's symptoms after subcutaneous injection of sumatriptan during a severe migraine attack. To this day, no triptan can provide greater relief than that provided by parenterally administered sumatriptan.
Why Does Sumatriptan Only Work for Headache Disorders?
Triptans have served as first-line therapy to treat migraine attacks ever since these drugs became commercially available in Europe in 1991. But precisely how they help, and where they act, has remained a source of debate in the field.

